ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL
Product details
Registration number: SIN15397P
Classification: Prescription Only
Active ingredients: Irinotecan (anhydrous free base)
Strength: 4.33 mg/mL
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: SERVIER (S) PTE LTD
ATC code: L01CE02
HSA approval date: 28 December 2017
Manufacturer(s):
- Ipsen Biosciences, Inc.
- Ajinomoto Althea, Inc.
- IPSEN PHARMA BIOTECH
Manufacturing country/countries: UNITED STATES; FRANCE
What are the HSA registration number and classification for ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15397P
Classification: Prescription Only
What active ingredients and strength are recorded for ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Irinotecan (anhydrous free base)
Strength: 4.33 mg/mL
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL?
According to the HSA dataset updated 7 August 2026:
Registrant: SERVIER (S) PTE LTD
Which manufacturers and countries are listed for ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Ipsen Biosciences, Inc.
- Ajinomoto Althea, Inc.
- IPSEN PHARMA BIOTECH
Manufacturing country/countries: UNITED STATES; FRANCE
Where can I look up ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15397P or the exact product name ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL. The general register link does not preselect this product.
What are the source dates for this ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15397P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)